These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12371924)

  • 1. Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis.
    Houi K; Kobayashi T; Kato S; Mochio S; Inoue K
    Acta Neurol Scand; 2002 Nov; 106(5):299-301. PubMed ID: 12371924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis.
    Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M
    Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis.
    Yan J; Xu Y; Zhang L; Zhao H; Jin L; Liu WG; Weng LH; Li ZH; Chen L
    Chin Med J (Engl); 2016 Dec; 129(23):2797-2803. PubMed ID: 27900991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentration of serum transforming growth factor beta-1 (TGF-beta1) is decreased in cervical carcinoma patients.
    Wu HS; Li YF; Chou CI; Yuan CC; Hung MW; Tsai LC
    Cancer Invest; 2002; 20(1):55-9. PubMed ID: 11853003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of plasma transforming growth factor beta1 levels in stable nonatopic asthma.
    Joseph J; Benedict S; Badrinath P; Wassef S; Joseph M; Abdulkhalik S; Nicholls MG
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):472-6. PubMed ID: 14692431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma transforming growth factor-beta1 in migraine.
    Ishizaki K; Takeshima T; Fukuhara Y; Araki H; Nakaso K; Kusumi M; Nakashima K
    Headache; 2005 Oct; 45(9):1224-8. PubMed ID: 16178953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
    Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
    Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases.
    Masuda T; Itoh J; Koide T; Tomidokoro Y; Takei Y; Ishii K; Tamaoka A
    J Clin Neurosci; 2017 Jan; 35():47-49. PubMed ID: 27756506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y; Kikuchi S; Obata Y; Yagyu K;
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of co-measured platelet factor 4 in the reliability of the results of the plasma transforming growth factor-beta 1 measurement.
    Jeon JH; Kim YS; Choi EJ; Cheon S; Kim S; Kim JS; Jang JS; Ha WS; Park ST; Park CS; Park K; Park BK
    Cytokine; 2001 Nov; 16(3):102-5. PubMed ID: 11741350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
    Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
    Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
    Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
    World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 and major trauma: time-dependent association with hepatic and renal insufficiency.
    Laun RA; Schröder O; Schoppnies M; Röher HD; Ekkernkamp A; Schulte KM
    Shock; 2003 Jan; 19(1):16-23. PubMed ID: 12558138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma TGF-beta1 as a risk factor for gingival overgrowth.
    Ellis JS; Morgan CL; Kirby JA; Taylor JJ; Thomason JM
    J Clin Periodontol; 2004 Oct; 31(10):863-8. PubMed ID: 15367190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased transforming growth factor beta1 plasma level in patients with renal cell carcinoma: a tumor-specific marker?
    Wunderlich H; Steiner T; Kosmehl H; Junker U; Reinhold D; Reichelt O; Zermann DH; Schubert J
    Urol Int; 1998 Aug; 60(4):205-7. PubMed ID: 9701731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.